Ultragenyx Pharmaceutical (UP0) Q2 2024 Earnings Report
DE:UP0 Q2 2024 EPS Results
- Actual EPS
- -EUR 1.36
- Consensus EPS
- -EUR 1.49
- Beat/Miss
- Beat by +EUR 0.13
- One Year Ago EPS
- -EUR 2.01
DE:UP0 Q2 2024 Revenue Results
- Actual Revenue
- EUR 131.65M
- Expected Revenue
- EUR 110.31M
- Beat/Miss
- Beat by +EUR 21.34M
- YoY Revenue Growth
- +35.75%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
DE:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:UP0 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | ―- | -1.16 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.98- | -1.62 | ― | |
| Aug 04, 2026 | 2026 (Q2) | -1.09-0.81 | -1.05 | 23.08% (+0.24) | |
| May 05, 2026 | 2026 (Q1) | -1.33-1.65 | -1.41 | -17.20% (-0.24) | |
| Feb 12, 2026 | 2025 (Q4) | -0.98-1.16 | -1.24 | 7.19% (+0.09) | |
| Nov 04, 2025 | 2025 (Q3) | -1.10-1.62 | -1.25 | -29.29% (-0.37) | |
| Aug 05, 2025 | 2025 (Q2) | -1.16-1.05 | -1.36 | 23.03% (+0.31) | |
| May 06, 2025 | 2025 (Q1) | -1.43-1.41 | -1.82 | 22.66% (+0.41) | |
| Feb 13, 2025 | 2024 (Q4) | -1.17-1.24 | -1.36 | 8.55% (+0.12) | |
| Nov 05, 2024 | 2024 (Q3) | -1.33-1.25 | -2 | 37.22% (+0.74) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
